Procter & Gamble’s €3.4 billion acquisition of Consumer Health business of Merck KGaA

Freshfields Bruckhaus Deringer LLP has advised Merck KGaA, a leading science and technology company in healthcare, life science and performance materials, on the sale of its global Consumer Health business to Procter & Gamble for approximately €3.4bn cash.

The transaction will be executed through the sale of Merck’s shares in a number of legal entities as well as various asset sales and comprises the Consumer Health business across 44 countries, including more than 900 products and two Consumer Health-managed production sites in Spittal (Austria) and Goa (India).

The cross-border Freshfields team is being led by partners Jennifer Bethlehem (picture), Jochen Dieselhorst and Lars Meyer, who are supported by employment and pensions partners Andrew Murphy and René Döring, partner Rod Carlton on antitrust, partner Christian Ruoff on tax and Michael Ramb and Marcel Kaufman from the regulatory practice group.

 

Involved fees earner: Jennifer Bethlehem – Freshfields Bruckhaus Deringer LLP; Lars Meyer – Freshfields Bruckhaus Deringer LLP; Andrew Murphy – Freshfields Bruckhaus Deringer LLP; René Döring – Freshfields Bruckhaus Deringer LLP; Jochen Dieselhorst – Freshfields Bruckhaus Deringer LLP; Rod Carlton – Freshfields Bruckhaus Deringer LLP; Christian Ruoff – Freshfields Bruckhaus Deringer LLP; Michael Ramb – Freshfields Bruckhaus Deringer LLP; Marcel Kaufmann – Freshfields Bruckhaus Deringer LLP;

Law Firms: Freshfields Bruckhaus Deringer LLP;

Clients: Merck KGaA;